Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Многоцентрово кохортно проучване× | Анализ на преживяемостта× | |
|---|---|---|
| Област≠ | Епидемиология | Статистика за изследвания |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | Mid-to-late 20th century (widespread adoption 1970s–1990s) | 1958 |
| Създател≠ | Developed incrementally through large collaborative epidemiological projects (e.g., Framingham Heart Study consortium expansions, 1948 onward; EPIC study, 1992) | Edward L. Kaplan and Paul Meier |
| Тип≠ | Observational longitudinal study | Method |
| Основополагащ източник≠ | Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641 | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ |
| Други названия≠ | multisite cohort study, multi-centre cohort, collaborative cohort study, pooled cohort study | Kaplan-Meier analysis, Cox regression, TTE analysis |
| Свързани≠ | 6 | 3 |
| Резюме≠ | A multicenter cohort study follows defined groups of participants at two or more geographically or institutionally distinct sites over time to estimate incidence, identify risk factors, and quantify associations between exposures and outcomes. By pooling data from multiple centers, it achieves statistical power and population diversity that single-site designs cannot match, making it the workhorse of large-scale epidemiological and clinical research. | Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters. |
| ScholarGateНабор от данни ↗ |
|
|